首页> 外文期刊>Saudi Pharmaceutical Journal >Targeting G protein coupled receptor-related pathways as emerging molecular therapies
【24h】

Targeting G protein coupled receptor-related pathways as emerging molecular therapies

机译:靶向G蛋白偶联受体相关途径作为新兴的分子疗法

获取原文
获取外文期刊封面目录资料

摘要

G protein coupled receptors (GPCRs) represent the most important targets in modern pharmacology because of the different functions they mediate, especially within brain and peripheral nervous system, and also because of their functional and stereochemical properties. In this paper, we illustrate, via a variety of examples, novel advances about the GPCR-related molecules that have been shown to play diverse roles in GPCR pathways and in pathophysiological phenomena. We have exemplified how those GPCRs' pathways are, or might constitute, potential targets for different drugs either to stimulate, modify, regulate or inhibit the cellular mechanisms that are hypothesized to govern some pathologic, physiologic, biologic and cellular or molecular aspects both in vivo and in vitro. Therefore, influencing such pathways will, undoubtedly, lead to different therapeutical applications based on the related pharmacological implications. Furthermore, such new properties can be applied in different fields. In addition to offering fruitful directions for future researches, we hope the reviewed data, together with the elements found within the cited references, will inspire clinicians and researchers devoted to the studies on GPCR's properties.
机译:G蛋白偶联受体(GPCR)代表了现代药理学中最重要的目标,因为它们介导的功能不同,尤其是在大脑和周围神经系统中,并且还具有功能和立体化学特性。在本文中,我们通过各种示例说明了有关GPCR相关分子的新进展,这些进展已显示在GPCR途径和病理生理现象中起着多种作用。我们已举例说明了这些GPCR的途径如何成为或可能构成不同药物的潜在靶标,以刺激,修饰,调节或抑制被假设在体内控制某些病理,生理,生物学和细胞或分子方面的细胞机制和体外。因此,毫无疑问,基于相关的药理学意义,影响这些途径将导致不同的治疗应用。此外,这样的新属性可以应用于不同的领域。除了为将来的研究提供富有成果的指导外,我们希望所审查的数据以及所引用参考文献中的内容能够启发致力于GPCR特性研究的临床医生和研究人员。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号